PacBio’s earnings surpassed the Zacks Consensus ... Continued strong prospects in the Revio and Onso systems, with customers placing orders for these, looked promising for the stock.

PacBio’s earnings surpassed the Zacks Consensus ... Joining the 10X Genomics Compatible Partner program integrates Onso into single-cell and spatial biology workflows, addressing growing market ...

University of Washington & UDN Research: Demonstrated PacBio’s ability to simultaneously analyze the genome, methylome, epigenome, and transcriptome, providing novel insights into a rare and ...